Celldex Therapeutics (CLDX) Amortizatization of Intangibles (2010 - 2026)
Celldex Therapeutics (CLDX) posted quarterly Amortizatization of Intangibles of $630000.0 for Q1 2026, down 72.21% year-over-year from $2.3 million in Q1 2025, and down 28.57% quarter-over-quarter from $882000.0 in Q4 2025.
Celldex Therapeutics (CLDX) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Amortizatization of Intangibles history runs 17 years deep, the most recent figure standing at $630000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 72.21% year-over-year to $630000.0; the TTM figure through Mar 2026 stood at $4.2 million (down 71.31% YoY), while the FY2025 annual figure was $5.9 million, down 62.82% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $630000.0, down from $882000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $4.7 million in Q2 2024, with the low at -$772000.0 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $1.3 million (2023), against an average of $1.6 million.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles sank 1708.33% in 2022, then soared 2905.17% in 2023.
- Celldex Therapeutics' Amortizatization of Intangibles stood at $522000.0 in 2022, then soared by 317.43% to $2.2 million in 2023, then jumped by 54.34% to $3.4 million in 2024, then plunged by 73.77% to $882000.0 in 2025, then retreated by 28.57% to $630000.0 in 2026.
- Business Quant data shows CLDX's Amortizatization of Intangibles at $630000.0 in Q1 2026, $882000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.33 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 678,000.00 |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | 1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.70 Mn |
| Jun 30, 2026 | 1.70 Mn |
| Mar 31, 2026 | 630,000.00 |
| Mar 31, 2026 | 630,000.00 |
| Dec 31, 2025 | 882,000.00 |
| Dec 31, 2025 | 882,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 3.36 Mn |
| Dec 31, 2024 | 3.36 Mn |
| Sep 30, 2024 | 4.33 Mn |
| Sep 30, 2024 | 4.33 Mn |
| Jun 30, 2024 | 4.74 Mn |
| Jun 30, 2024 | 4.74 Mn |
| Mar 31, 2024 | 3.31 Mn |
| Mar 31, 2024 | 3.31 Mn |